BioCentury
ARTICLE | Clinical News

Octaplex regulatory update

December 13, 2010 8:00 AM UTC

FDA granted Fast Track designation for Octapharma's octaplex for the reversal of anticoagulation therapy in patients receiving vitamin K antagonist therapy in need of urgent surgery or invasive proced...